CN1620298A - 替勃龙用于治疗与施用阻止内源性雌激素合成的药物有关的疾病 - Google Patents
替勃龙用于治疗与施用阻止内源性雌激素合成的药物有关的疾病 Download PDFInfo
- Publication number
- CN1620298A CN1620298A CNA038025108A CN03802510A CN1620298A CN 1620298 A CN1620298 A CN 1620298A CN A038025108 A CNA038025108 A CN A038025108A CN 03802510 A CN03802510 A CN 03802510A CN 1620298 A CN1620298 A CN 1620298A
- Authority
- CN
- China
- Prior art keywords
- estrogen
- treatment
- tibolone
- drugs
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075235.8 | 2002-01-22 | ||
| EP02075235 | 2002-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1620298A true CN1620298A (zh) | 2005-05-25 |
Family
ID=27589110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA038025108A Pending CN1620298A (zh) | 2002-01-22 | 2003-01-16 | 替勃龙用于治疗与施用阻止内源性雌激素合成的药物有关的疾病 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050124592A1 (https=) |
| EP (1) | EP1469861A1 (https=) |
| JP (1) | JP2005518412A (https=) |
| KR (1) | KR20040073572A (https=) |
| CN (1) | CN1620298A (https=) |
| BR (1) | BR0306789A (https=) |
| CA (1) | CA2472240A1 (https=) |
| EC (1) | ECSP045179A (https=) |
| HR (1) | HRP20040635A2 (https=) |
| IL (1) | IL162769A0 (https=) |
| IS (1) | IS7338A (https=) |
| MX (1) | MXPA04007071A (https=) |
| PL (1) | PL371181A1 (https=) |
| RU (1) | RU2004125594A (https=) |
| WO (1) | WO2003061665A1 (https=) |
| ZA (1) | ZA200405262B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0302572D0 (en) | 2003-02-05 | 2003-03-12 | Astrazeneca Ab | Method of treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE63051B1 (en) * | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
| ES2134313T3 (es) * | 1993-03-05 | 1999-10-01 | Akzo Nobel Nv | Utilizacion de derivados de pregnano para el tratamiento de tumores. |
| EP1102755B1 (en) * | 1998-08-07 | 2006-01-04 | Chiron Corporation | Substituted isoxazole derivatives as estrogen receptor modulators |
-
2003
- 2003-01-16 JP JP2003561609A patent/JP2005518412A/ja active Pending
- 2003-01-16 CN CNA038025108A patent/CN1620298A/zh active Pending
- 2003-01-16 US US10/502,444 patent/US20050124592A1/en not_active Abandoned
- 2003-01-16 BR BR0306789-0A patent/BR0306789A/pt not_active IP Right Cessation
- 2003-01-16 PL PL03371181A patent/PL371181A1/xx not_active Application Discontinuation
- 2003-01-16 KR KR10-2004-7011160A patent/KR20040073572A/ko not_active Withdrawn
- 2003-01-16 IL IL16276903A patent/IL162769A0/xx unknown
- 2003-01-16 RU RU2004125594/14A patent/RU2004125594A/ru not_active Application Discontinuation
- 2003-01-16 HR HR20040635A patent/HRP20040635A2/hr not_active Application Discontinuation
- 2003-01-16 EP EP20030731620 patent/EP1469861A1/en not_active Withdrawn
- 2003-01-16 MX MXPA04007071A patent/MXPA04007071A/es not_active Application Discontinuation
- 2003-01-16 WO PCT/EP2003/000373 patent/WO2003061665A1/en not_active Ceased
- 2003-01-16 CA CA002472240A patent/CA2472240A1/en not_active Abandoned
-
2004
- 2004-06-28 IS IS7338A patent/IS7338A/is unknown
- 2004-07-01 ZA ZA2004/05262A patent/ZA200405262B/en unknown
- 2004-07-06 EC EC2004005179A patent/ECSP045179A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04007071A (es) | 2004-10-29 |
| ECSP045179A (es) | 2004-08-27 |
| BR0306789A (pt) | 2004-12-28 |
| US20050124592A1 (en) | 2005-06-09 |
| HRP20040635A2 (en) | 2004-10-31 |
| IS7338A (is) | 2004-06-28 |
| RU2004125594A (ru) | 2005-03-10 |
| EP1469861A1 (en) | 2004-10-27 |
| JP2005518412A (ja) | 2005-06-23 |
| CA2472240A1 (en) | 2003-07-31 |
| IL162769A0 (en) | 2005-11-20 |
| PL371181A1 (en) | 2005-06-13 |
| ZA200405262B (en) | 2005-08-31 |
| KR20040073572A (ko) | 2004-08-19 |
| WO2003061665A1 (en) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1104243C (zh) | 芳化酶抑制剂用于制备治疗男性雄激素相对缺乏的药物的用途 | |
| CA2394165A1 (en) | Drospirenone for hormone replacement therapy | |
| CA2446849A1 (en) | Treatment of conditions relating to hormone deficiencies by administration of progestins | |
| US20110009373A1 (en) | Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis | |
| US20050222100A1 (en) | Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm | |
| KR19990087573A (ko) | 데히드로에피안드로스테론과 아로마타제 저해제의 조합 제제,및 남성의 상대적 및 절대적 안드로겐 결핍증 치료용 약제 제조를 위한 이 조합 제제의 용도 | |
| CN1620298A (zh) | 替勃龙用于治疗与施用阻止内源性雌激素合成的药物有关的疾病 | |
| AU2003236806A1 (en) | Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen | |
| CN1658885A (zh) | 激素替代治疗 | |
| CN1658886A (zh) | 激素替代疗法 | |
| IL126176A (en) | Pharmaceutical packaging unit containing estrogen and progesterone antagonist for stepwise hormonal therapy | |
| CN1649595A (zh) | 结合型雌激素与曲美孕酮相联合在激素替代疗法中的用途 | |
| JPH10279483A (ja) | 骨密度増加剤 | |
| EP1522306A1 (en) | A pharmaceutical product for hormone replacement therapy comprising tibolone or a derivative thereof and estradiol or a derivative thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20061229 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20061229 Address after: Holland Applicant after: Organon NV Address before: Holland Arnhem Applicant before: Akzo Nobel N. V. |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |